Respiratory Therapeutics is the Largest Segment Driving the Growth of Pulmonary Drugs Market

The global Pulmonary Drugs Market is estimated to be valued at US$ 3.41 Bn in 2023 and is expected to exhibit a CAGR of 8.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Pulmonary drugs are beneficial for the treatment of respiratory diseases like asthma, cystic fibrosis, chronic obstructive pulmonary disease and other lung disorders. These drugs help in improving lung function, alleviate symptoms and control airway inflammation.

Market Key Trends:
One of the key trends witnessed in the pulmonary drugs market is the growing preference for nebulized delivery of drugs over conventional methods. Nebulizers offer several advantages like direct delivery of drugs to the lungs, lower drug dosage requirement and better lung deposition. They have emerged as an effective alternative for patients unable to use pressurized metered dose inhalers or dry powder inhalers. Several new drug-device combination products are being launched incorporating nebulized delivery systems.

Market key trends:

The global pulmonary drugs market has been witnessing high growth owing to the increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Rising environmental pollution levels, growing geriatric population, and changing lifestyle habits resulting in smoking have been key drivers for the growth of the market. Furthermore, the development and launch of novel biologics and formulations for improved treatment of respiratory disorders is expected to drive the market during the forecast period.

SWOT Analysis

Strength: Wide range of drugs available for treatment of pulmonary diseases. Growing awareness regarding respiratory illnesses.
Weakness: High costs associated with development of novel treatment regimens. Side effects of few drugs discourage compliance.
Opportunity: Rising pollution and urbanization in developing nations present an opportunity. Untapped rural markets yet to adopt pulmonary drugs.
Threats: Patent expiry of blockbuster drugs. Slow regulatory approval process delays market entry.

Key Takeaways

Global Pulmonary Drugs Market Size is expected to witness high growth, exhibiting CAGR of 8.1% over the forecast period, due to increasing prevalence of respiratory diseases across both developed and developing nations.

The regional analysis indicates that North America dominated the market in 2023, owing to growing elderly population, favorable reimbursement policies, and strong presence of key players in the region. However, Asia Pacific is anticipated to witness fastest growth during the forecast period due to rising pollution levels, growing healthcare expenditure, and favourable government support.

Key players operating in the pulmonary drugs market are Sanofi SA, Meda Pharmaceuticals, Circassia Pharmaceuticals Plc., AstraZenca Plc., GlaxoSmithKline Plc., Mallinckrodt Pharmaceuticals Plc., Cheisi farmaceutici S.p.A., Zambon Company S.p.A., Alaxia SAS, and Merck Sharp & Dohme Limited. The market is highly competitive with these players introducing generic versions for drugs losing patents and focusing on development of innovative delivery systems. 

Read More- https://www.trendingwebwire.com/pulmonary-drugs-market-size-share-and-demand-analysis/

8 thoughts on “Respiratory Therapeutics is the Largest Segment Driving the Growth of Pulmonary Drugs Market”

  1. 2023-24英超聯賽萬眾矚目,2023年8月12日開啟了第一場比賽,而接下來的賽事也正如火如荼地進行中。本文統整出英超賽程以及英超賽制等資訊,幫助你更加了解英超,同時也提供英超直播平台,讓你絕對不會錯過每一場精彩賽事。

    英超是什麼?
    英超是相當重要的足球賽事,以競爭激烈和精彩程度聞名
    英超是相當重要的足球賽事,以競爭激烈和精彩程度聞名
    英超全名為「英格蘭足球超級聯賽」,是足球賽事中最高級的足球聯賽之一,由英格蘭足球總會在1992年2月20日成立。英超是全世界最多人觀看的體育聯賽,因其英超隊伍全球知名度和競爭激烈而聞名,吸引來自世界各地的頂尖球星前來參賽。

    英超聯賽(English Premier League,縮寫EPL)由英國最頂尖的20支足球俱樂部參加,賽季通常從8月一直持續到5月,以下帶你來了解英超賽制和其他更詳細的資訊。

    英超賽制
    2023-24英超總共有20支隊伍參賽,以下是英超賽制介紹:

    採雙循環制,分主場及作客比賽,每支球隊共進行 38 場賽事。
    比賽採用三分制,贏球獲得3分,平局獲1分,輸球獲0分。
    以積分多寡分名次,若同分則以淨球數來區分排名,仍相同就以得球計算。如果還是相同,就會於中立場舉行一場附加賽決定排名。
    賽季結束後,根據積分排名,最高分者成為冠軍,而最後三支球隊則降級至英冠聯賽。
    英超升降級機制
    英超有一個相當特別的賽制規定,那就是「升降級」。賽季結束後,積分和排名最高的隊伍將直接晉升冠軍,而總排名最低的3支隊伍會被降級至英格蘭足球冠軍聯賽(英冠),這是僅次於英超的足球賽事。

    同時,英冠前2名的球隊直接升上下一賽季的英超,第3至6名則會以附加賽決定最後一個升級名額,英冠的隊伍都在爭取升級至英超,以獲得更高的收入和榮譽。

    Reply

Leave a Comment